Trusted News Discovery Since 2008
{{/content}}
U.S. pauses Eli Lilly antibody drug trial over safety concern
Video Credit: Reuters Studio
Published on October 15, 2020 - Duration: 01:12s
U.S. pauses Eli Lilly antibody drug trial over safety concern
Eli Lilly and Co said on Tuesday that the government-sponsored clinical trial of its COVID-19 antibody treatment similar to one taken by U.S. President Donald Trump has been paused because of a safety concern.
This report produced by Jillian Kitchener.
You are here
Related videos from verified sources
Regeneron says its COVID-19 drug cut patient visits 01:56
Video credit: Reuters - Politics - Published on October 29, 2020
Jim Cramer Says Pause in Eli Lilly Trial Is 'Very Big Deal' 01:17
Video credit: The Street - Published on October 14, 2020
FDA faults quality control at Eli Lilly plant 01:36
Video credit: Reuters Studio - Published on October 14, 2020